T
The Cat Health Company
Feline longevity research developing therapeutics for aging
About The Cat Health Company
The Cat Health Company is a biotechnology startup dedicated to advancing feline longevity and healthspan. Founded in 2024 by scientists Alex Voda and Alex Bacita, the company focuses on discovering and developing new treatments for age-related diseases in cats. The two founders met during their studies at The University of Manchester and collaborated for a decade before establishing the company. Voda holds a PhD in Molecular and Cellular Medicine from Oxford, while Bacita previously served as a Senior Scientist at Charles River Laboratories, combining expertise in computational algorithms and drug discovery services.
The company's core technology leverages an in silico, or computational, research platform to rapidly analyze vast libraries of drug candidates. This computer-driven approach aims to accelerate the identification of promising therapies and reduce development costs compared to traditional methods. The primary business activity is research and development, with plans to subcontract manufacturing and sales to partners in the pharmaceutical sector. The business model is described as B2B2C (business-to-business-to-consumer), intending to provide regulated solutions through collaborations with veterinary practices and clinics.
Headquartered in Bucharest, Romania, with a U.S. entity registered as a Delaware C-Corporation, The Cat Health Company operates in the growing pet longevity market. In 2024, the startup secured a €500,000 pre-seed funding round led by Early Game Ventures with participation from Ani.VC and several angel investors. This capital is intended to fund initial clinical trials and team expansion. While its immediate focus is on feline health, the company notes that its research has the long-term potential to be extended to human longevity therapies.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Oct 2025 | $0 | — | Alex Zhavoronkov · 100pluscap · Early Game Ventures · Portfolia Funds | ↗ |
| SEED✓Equity / VC | Sep 2024 | $552K | $2.2M | Early Game Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for The Cat Health Company is 2.1K monthly website visits, up 517.6% over the last three months. The Cat Health Company's team grew 250% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
The Cat Health Company in the Bucharest ecosystem
The The Cat Health Company office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Early Game Ventures
Alex Zhavoronkov- 10100pluscap
Portfolia Funds
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about The Cat Health Company on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See The Cat Health Company’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










